Literature DB >> 3623679

Calcium, the renin-aldosterone system, and the hypotensive response to nifedipine.

L M Resnick, J P Nicholson, J H Laragh.   

Abstract

Ionic, hormonal, and blood pressure responses to a single oral dose of the calcium channel blocker nifedipine were assessed in 25 essential hypertensive subjects. When grouped according to their renin-sodium profile, low renin subjects had a greater hypotensive response to nifedipine (change in diastolic blood pressure -20.0 +/- 1.4 vs -6.4 +/- 1.0%; p less than 0.005) than did high renin hypertensive subjects. The initial level of serum ionized calcium predicted the blood pressure response to nifedipine (r = 0.70, p less than 0.001), as did the initial plasma renin activity (r = 0.65, p less than 0.005). Nifedipine induced a transient rise in serum ionized calcium (from 2.22 +/- 0.02 to 2.28 +/- 0.02 mEq/L; p less than 0.01), while plasma renin activity was consistently elevated compared with initial values at 30 (p less than 0.01), 60 (p less than 0.01), and 120 (p less than 0.05) minutes after drug administration. By comparison, plasma aldosterone levels did not rise and even declined at 30 (p less than 0.01), 60 (p less than 0.05), and 120 (p less than 0.05) minutes after nifedipine. These results suggest that low renin hypertension is more critically dependent on extracellular calcium than are higher renin forms and demonstrate that levels of serum ionized calcium, plasma renin activity, or both may predict the sensitivity of blood pressure to calcium channel blockade. Lastly, calcium may play a pivotal role in vivo in coupling renin stimulation to adrenal aldosterone responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623679     DOI: 10.1161/01.hyp.10.3.254

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

2.  Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.

Authors:  T Baba; S Murabayashi; K Takebe
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

Review 3.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

4.  Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade.

Authors:  L M Resnick; R K Gupta; B DiFabio; M Barbagallo; S Mann; R Marion; J H Laragh
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 5.  Secondary hypertension. An overview of its causes and management.

Authors:  D H Streeten; G H Anderson
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

Review 6.  Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Authors:  Michael R Seawell; Fahed Al Darazi; Victor Farah; Kodangudi B Ramanathan; Kevin P Newman; Syamal K Bhattacharya; Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2013-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.